MERIT MEDICAL SYSTEMS INC — Director's Dealing 2021

Mar 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2021-03-12

Reporting Person: LAMPROPOULOS FRED P (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-12	Common Stock, No Par Value	S	4947	$59.60	Disposed	967916	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, No Par Value	95862.542	Indirect
Common Stock, No Par Value	90	Indirect
Common Stock, No Par Value	1269	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-qualified stock options (right to buy)	$17.27	2022-02-13	Common Stock (5000)	5000	Indirect
Non-qualified stock options (right to buy)	$16.05	2023-01-28	Common Stock (50000)	50000	Direct
Non-qualified stock options (right to buy)	$16.05	2023-01-28	Common Stock (6000)	6000	Indirect
Non-qualified stock options (right to buy)	$28.20	2024-04-14	Common Stock (200000)	200000	Direct
Non-qualified stock options (right to buy)	$28.20	2024-04-14	Common Stock (6000)	6000	Indirect
Non-qualified stock options (right to buy)	$44.80	2025-03-02	Common Stock (38002)	38002	Direct
Non-qualified stock options (right to buy)	$44.80	2025-03-02	Common Stock (4000)	4000	Indirect
Non-qualified stock options (right to buy)	$55.73	2026-03-01	Common Stock (159151)	159151	Direct
Non-qualified stock options (right to buy)	$55.73	2026-03-01	Common Stock (2000)	2000	Indirect
Non-qualified stock options (right to buy)	$37.71	2027-02-26	Common Stock (100334)	100334	Direct

Footnotes

F1: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.60 to $59.63, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F2: Represents plan holdings as of 2/26/2021.

F3: Became exercisable in equal annual installments of 20% commencing 2/13/2016.

F4: Represents derivative securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse.

F5: Becomes exercisable in equal annual installments of 20% commencing 1/28/2017.

F6: Original grant of 7,500 options was to become vested and exercisable in equal annual installments of 20% commencing 1/28/2017. Options not vested as of 6/22/2020 have been forfeited.

F7: Becomes exercisable in equal annual installments of 20% commencing 4/14/2018.

F8: Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 4/14/2018. Options not vested as of 6/22/2020 have been forfeited.

F9: Becomes exercisable in equal annual installments of 20% commencing 3/2/2019.

F10: Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/2/2019. Options not vested as of 6/22/2020 have been forfeited.

F11: Becomes exercisable in equal annual installments of 20% commencing 3/1/2020.

F12: Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited.

F13: Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.